Dow Jones Newswires: Daiichi Sankyo shares jump on multibillion-dollar drug development deal with Merck

Daiichi Sankyo shares rose sharply after the Japanese drugmaker announced a multibillion dollar deal with Merck to jointly develop and commercialize three cancer drug candidates.

Previous post Next Avenue: Trust no one: How to spot and avoid smishing scams
Next post Dow Jones Newswires: China holds benchmark lending rates steady